Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dräger Award for Intensive Care Medicine bestowed

02.06.2008
At this year's Congress of the European Society of Anaesthesiology (ESA), Euroanaesthesia 2008, in Copenhagen, the ESA presented the “Dräger Award for Intensive Care Medicine”. The 10,000 Euro endowment was donated by Dräger.

The award went to the working group studying “Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis” in the Department of Anesthesiology, Rigshospitalet, at the Juliane Marie Centre and Copenhagen Trial Unit, University of Copenhagen, Denmark.


During the opening ceremony, Professor Jennifer M Hunter, Chairperson of the ESA Scientific Programme Committee, together with Dr Markus Keussen, Head of Dräger Strategic Business Field Anesthesiology, presented the award to Dr Arash Afshari, representing this working group.

The prize
This annual prize honors significant European research in the field of intensive care medicine published in peer-reviewed intensive care or anesthesiology journals in the preceding year. The prize is given to the anesthetic or intensive care department that produces the article rather than any one research worker.

This year, the Dräger Prize subcommittee of the ESA who judged the prize recognized this working group for their systematic, detailed and methodical approach in a large meta-analysis of the effects of anti-thrombin III in critically ill patients.

With this prize, Dräger wishes to honor scientific endeavors and support advances in the field of critical care medicine.

The award recipients
Dr Afshari’s working group has brought together all the published papers on the role of one of the body’s anti-clotting proteins (which also has anti-inflammatory properties), anti-thrombin III, to study its benefits or harm when it is given to critically ill patients. Data from 3458 patients was available suggesting that this clotting product was not suitable to give to intensive care patients despite its anti-inflammatory effects: the risk of excessive bleeding was too great.

As Chairman of the Dräger Prize Subcommittee, Prof Jennifer M. Hunter MB ChB PhD FRCA, School of Clinical Science (Anaesthesia), University of Liverpool, UK, stated that this paper was selected as it showed the highest standard of scientific study of all the submissions, with results that were most likely to affect future clinical practice.

About Dräger
Drägerwerk AG & Co. KGaA is an international leader in the fields of medical and safety technology: Dräger products protect, support and save human life. Founded in 1889, in 2007 the Group achieved sales of 1,819.5 million Euro worldwide and an EBIT of 151.9 million Euro. Today, Dräger employs around 10,000 people in more than 70 subsidiaries worldwide and has representation in around 190 countries. The Dräger Medical subsidiary offers products, services and integrated system solutions which accompany the patient throughout the care process - Emergency Care, Perioperative Care, Critical Care, Perinatal Care and Home Mechanical Ventilation.
1) Head of the working group: Dr Arash Afshari; members: Dr Jorn Wetterslev,
Dr Jesper Brok, Dr Ann Moller, all of the Rigshospitalet, at the Juliane Marie Centre the Copenhagen Trial Unit and the Cochrane Anaesthesia Review Group, University of Copenhagen, Denmark.

2) BMJ 2007; 335: 1248-51
Contact for Trade Press:
Birgit Diekmann
Tel.: +49 451 882 1215
E-mail: birgit.diekmann@draeger.com

Birgit Diekmann | Drägerwerk AG & Co. KGaA
Further information:
http://www.draeger.com

More articles from Awards Funding:

nachricht Yuan Chang and Patrick Moore win prize for the discovery of two cancer viruses
14.03.2017 | Goethe-Universität Frankfurt am Main

nachricht BMBF funding for diabetes research on pancreas chip
08.02.2017 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>